CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand

Publisher Name :
Date: 09-Nov-2016
No. of pages: 229
Inquire Before Buying

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2015, the population of Thailand 68.84 million, and it is estimated to reach 69.31 million by 2020. The value of the pharmaceutical market was estimated at $5.91 billion in 2015, and is expected to reach $9.47 billion in 2020, increasing at a projected CAGR of 10%.

The positive trends in the healthcare market of Thailand can be attributed primarily to -


  • Increasing medical tourism

  • Increasing health awareness

  • Greater access to life-saving facilities


Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes -


  • An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers

  • Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline (GSK), Sanofi, Roche, AstraZeneca and Novartis.

  • An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices

  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures

  • An overview of the opportunities and challenges for growth in the healthcare market


Reasons to buy

This report will enhance your decision-making capability by allowing you to -


  • Develop business strategies by understanding the trends shaping and driving Thailand's healthcare market

  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Thailand's healthcare market in the future

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance

  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand

Table of Contents

1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 12

2 Introduction 16
2.1 GlobalData Report Guidance 16

3 Overview of Pharmaceutical and Medical Device Markets 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Pharmaceutical Import and Export 21
3.1.3 Supply Channels 23
3.1.4 Market Segments 25
3.1.5 Major Therapeutic Areas 28
3.1.6 Major Companies 31
3.2 Medical Device Market 90
3.2.1 Market Overview 90
3.3 Market Drivers and Barriers 93
3.3.1 Drivers 93
3.3.2 Barriers 95

4 Market Access 97
4.1 Reimbursement and Payer Landscape 97
4.1.1 Overview of Healthcare system 97
4.1.2 Reimbursement Process 100
4.1.3 Overview of Insurance Providers 103
4.1.4 Patient Share in Healthcare Spending 105
4.1.5 Price Trends in the Healthcare Sector 106
4.1.6 Pricing Policies 107
4.2 Regulatory Landscape 108
4.2.1 Overview of Regulatory Agencies 108
4.2.2 Market Authorization Procedure for Pharmaceutical Products 110
4.2.3 New Medical Device Approval Process 117
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 119
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 120
4.2.6 Intellectual Property Rights 122
4.2.7 Clinical Trial Regulations 130
4.2.8 Pharmaceutical Advertising Regulations 132
4.2.9 Pharmacy Regulations 133
4.2.10 Labelling and Packaging Regulations 134

5 Country Analysis 136
5.1 Political Environment 136
5.1.1 Political Structure 136
5.1.2 Analysis of the Current Political Environment 138
5.1.3 Healthcare Policy Initiatives 141
5.2 Economic Landscape 142
5.3 Economic Indicators 146
5.3.1 Gross Domestic Product 146
5.3.2 Gross National Income 150
5.3.3 Inflation 151
5.3.4 Currency Exchange Rate 155
5.3.5 Foreign Direct Investment 156
5.3.6 Foreign Exchange Reserves 157
5.3.7 Trade Balance 158
5.3.8 Government Structural Balance 161
5.3.9 Government Net Debt 162
5.3.10 Major Industries 164
5.4 Demographics 166
5.4.1 Population 166
5.4.2 Education and Literacy 184
5.4.3 Employment 185
5.4.4 Disease Burden 186
5.5 Healthcare Infrastructure 188
5.5.1 Healthcare Facilities 188
5.5.2 Healthcare Parameters 194
5.5.3 Environmental Health 196
5.5.4 Healthcare Personnel 198
5.6 Healthcare Expenditure 201
5.6.1 Overview of Healthcare Expenditure 201
5.6.2 Major Components of Healthcare Expenditure 202
5.6.3 Healthcare Expenditure Distribution 203
5.6.4 Spending in Pharmaceutical R&D 204
5.7 Trade Associations 206
5.7.1 Thai Pharmaceutical Manufacturers Association 206
5.7.2 Thai Medical Technology Industry Association 206
5.7.3 Thai Self-Medication Industry Association 206
5.7.4 The Medical Association of Thailand 206
5.8 Trade Fairs 206

6 Opportunities and Challenges 208
6.1 Opportunities 208
6.2 Challenges 208

7 Appendix 210
7.1 Abbreviations 210
7.2 Bibliography 214
7.3 Research Methodology 226
7.3.1 Coverage 226
7.3.2 Secondary Research 227
7.3.3 Forecasts 228
7.3.4 Expert Panel 228
7.4 Disclaimer 228

List of Tables

Table 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008-2015 20
Table 2: Pharmaceutical Market, Thailand, Revenue ($bn), 2016-2020 21
Table 3: Pharmaceutical Imports and Exports, Thailand, Revenue ($bn), 2008-2015 22
Table 4: Pharmaceutical Market, Thailand, Pharmaceutical Product Sales by Segment (%), 2015 25
Table 5: Major Therapeutic Areas, Thailand, Prevalence (%), 2010 28
Table 6: Major Products, GSK, Global, 2015 32
Table 7: Late-Stage Pipeline, GSK, Global, 2015 36
Table 8: Major Products, Sanofi, Global, 2015 45
Table 9: Late-Stage Pipeline, Sanofi, Global, 2015 48
Table 10: Major Products, Roche, Global, 2015 55
Table 11: Late-Stage Pipeline, Roche, Global, 2016 58
Table 12: Major Products, AstraZeneca, Global, 2016 68
Table 13: Planned Filings, AstraZeneca, Global, 2016 69
Table 14: Major Products, Novartis, Global, 2016 81
Table 15: Late-Stage Pipeline, Novartis, Global, 2015 82
Table 16: Medical Device Market, Thailand, Revenue ($bn), 2008-2015 91
Table 17: Medical Device Market, Thailand, Revenue ($bn), 2016-2020 92
Table 18: Public Health Insurance Schemes, Thailand, 2016 104
Table 19: Health Benefits Coverage, Thailand, 2011 105
Table 20: Market Access, Thailand, Patient Share of Total Health Expenditure (%), 2008-2015 106
Table 21: Market Access, Thailand, Producer Price Change (%), 2008-2015 107
Table 22: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2008-2015 147
Table 23: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2016-2020 148
Table 24: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2008-2015 149
Table 25: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2016-2020 150
Table 26: Economic Indicators, Thailand, Gross National Income per Capita ($), 2008-2014 151
Table 27: Economic Indicators, Thailand, Consumer Price Index, 2008-2015 152
Table 28: Economic Indicators, Thailand, Consumer Price Index, 2016-2020 153
Table 29: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2008-2015 154
Table 30: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2016-2020 155
Table 31: Economic Indicators, Thailand, Currency Exchange Rate (THB/$), 2008-2015 156
Table 32: Economic Indicators, Thailand, Foreign Direct Investment ($bn), 2008-2014 157
Table 33: Economic Indicators, Thailand, Foreign Exchange Reserves ($bn), 2008-2014 158
Table 34: Economic Indicators, Thailand, Imports of Goods and Services ($bn), 2008-2014 159
Table 35: Economic Indicators, Thailand, Exports of Goods and Services ($bn), 2008-2014 161
Table 36: Economic Indicators, Thailand, Government Structural Balance ($bn), 2008-2015 162
Table 37: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2008-2015 163
Table 38: Economic Indicators, Thailand, General Government Net Debt, (% of GDP), 2016-2020 164
Table 39: Major Industries, Thailand, Share of GDP at Current Market Prices (%), 2014 165
Table 40: Demographics, Thailand, Population (million), 2008-2015 167
Table 41: Demographics, Thailand, Population (million), 2016-2020 168
Table 42: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2008-2015 169
Table 43: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2016-2020 170
Table 44: Demographics, Thailand, Population Distribution (%), 2008-2015 172
Table 45: Demographics, Thailand, Population Distribution (%), 2016-2020 172
Table 46: Demographics, Thailand, Births (per 1,000 population), 2008-2015 173
Table 47: Demographics, Thailand, Mortality (per 1,000 population), 2008-2015 174
Table 48: Demographics, Major Causes of Mortality, Thailand, Share of Total Mortality (%), 2014 176
Table 49: Demographics, Thailand, Children Under Five Years of Age, Mortality (per 1,000 live births), 2008-2015 177
Table 50: Demographics, Thailand, Immunization Rate (%), 2008-2015 178
Table 51: Demographics, Thailand, Major Causes of Male Mortality (Share %), 2010 179
Table 52: Demographics, Thailand, Major Causes of Female Mortality (Share%), 2010 180
Table 53: Demographics, Thailand, Gender Ratio (M/F), 2008-2015 181
Table 54: Demographics, Thailand, Life Expectancy at Birth (years), 2008-2015 183
Table 55: Demographics, Thailand, Life Expectancy at Birth (Years), 2016-2020 183
Table 56: Demographics, Thailand, Gross Enrolment Ratio (%), 2008-2015 185
Table 57: Demographics, Thailand, Unemployment Rate (%), 2008-2015 186
Table 58: Demographics, Thailand, Major Diseases, DALYs, 2012 188
Table 59: Healthcare Infrastructure, Thailand, Hospitals, 2008-2015 189
Table 60: Healthcare Infrastructure, Thailand, Public and Private Hospitals, 2008-2015 190
Table 61: Healthcare Infrastructure, Thailand, Hospitals by Standard of Care, Share (%), 2010 192
Table 62: Healthcare Infrastructure, Thailand, Hospital Beds by Authority and Region, Share (%), 2010 193
Table 63: Healthcare Infrastructure, Thailand, Hospital Beds (per 1,000 population), 2008-2015 194
Table 64: Healthcare Infrastructure, Thailand, Doctors (per 1,000 Population), 2008-2015 195
Table 65: Healthcare Infrastructure, Thailand, PM2.5 emissions (µgm/m³), 2008-2015 197
Table 66: Healthcare Infrastructure, Thailand, CO2 Emissions (Metric Tons Per Capita), 2008-2015 198
Table 67: Healthcare Infrastructure, Thailand, Dentists (per 100,000 population), 2008-2015 199
Table 68: Healthcare Infrastructure, Thailand, Nurses (per 100,000 population), 2008-2015 200
Table 69: Healthcare Infrastructure, Thailand, Pharmacists (per 100,000 population), 2008-2015 201
Table 70: Healthcare Expenditure (% of GDP), Thailand, 2008-2015 202
Table 71: Healthcare Expenditure, Thailand, Major Components of Healthcare Expenditure (%), 2012 203
Table 72: Healthcare Expenditure, Thailand, Public and Private Shares of GDP (%), 2008-2015 204
Table 73: Healthcare Expenditure, Thailand, R&D Expenditure (% of GDP), 2008-2015 206
Table 74: Healthcare Expenditure, Thailand, Major Healthcare Trade Fairs, 2017 207

List of Figures

Figure 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008-2015 20
Figure 2: Pharmaceutical Market, Thailand, Revenue ($bn), 2016-2020 21
Figure 3: Pharmaceutical Imports and Exports, Thailand, Revenue ($bn), 2008-2015 22
Figure 4: Pharmaceutical Industry, Thailand, Structure, 2016 24
Figure 5: Pharmaceutical Market, Thailand, Pharmaceutical Product Sales by Segment (%), 2015 24
Figure 6: Major Therapeutic Areas, Thailand, Prevalence (%), 2010 28
Figure 7: Medical Device Market, Thailand, Revenue ($bn), 2008-2015 91
Figure 8: Medical Device Market, Thailand, Revenue ($bn), 2016-2020 92
Figure 9: Drivers and Barriers, Healthcare Market, Thailand, 2016 96
Figure 10: Reimbursement Fund Flow, Thailand, 2016 99
Figure 11: Health Insurance Development, Thailand, 2016 100
Figure 12: Addition to National List of Essential Drugs, Thailand, 2016 102
Figure 13: Drug Procurement Process, Thailand, 2016 103
Figure 14: Health Benefits Coverage, Thailand, 2011 104
Figure 15: Market Access, Thailand, Patient Share of Total Health Expenditure (%), 2008-2015 106
Figure 16: Market Access, Thailand, Producer Price Change (%), 2008-2015 107
Figure 17: Food and Drug Administration, Thailand, Structure, 2016 110
Figure 18: Marketing Authorization Procedure, New Drugs, Thailand, 2016 113
Figure 19: Marketing Authorization Procedure, Generics, Thailand, 2016 115
Figure 20: Marketing Authorization Procedure, New Generic Drugs, Thailand, 2016 117
Figure 21: Import Licensing Process for General Medical Device, Thailand, 2016 122
Figure 22: Patent Approval Process, Thailand, 2016 126
Figure 23: Trademark Approval Process, Thailand, 2016 130
Figure 24: Clinical Trial Regulation Process, Thailand, 2016 132
Figure 25: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2008-2015 147
Figure 26: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2016-2020 148
Figure 27: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2008-2015 149
Figure 28: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2016-2020 150
Figure 29: Economic Indicators, Thailand, Gross National Income per Capita ($), 2008-2015 151
Figure 30: Economic Indicators, Thailand, Consumer Price Index, 2008-2015 152
Figure 31: Economic Indicators, Thailand, Consumer Price Index, 2016-2020 153
Figure 32: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2008-2015 154
Figure 33: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2016-2020 155
Figure 34: Economic Indicators, Thailand, Currency Exchange Rate (THB/$), 2008-2015 156
Figure 35: Economic Indicators, Thailand, Foreign Direct Investment ($bn), 2008-2014 157
Figure 36: Economic Indicators, Thailand, Foreign Exchange Reserves ($bn), 2008-2014 158
Figure 37: Economic Indicators, Thailand, Imports of Goods and Services ($bn), 2008-2014 159
Figure 38: Economic Indicators, Thailand, Exports of Goods and Services ($bn), 2008-2014 160
Figure 39: Economic Indicators, Thailand, Government Structural Balance ($bn), 2008-2015 162
Figure 40: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2008-2015 163
Figure 41: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2016-2020 164
Figure 42: Major Industries, Thailand, Share of GDP at Current Market Prices (%), 2014 165
Figure 43: Demographics, Thailand, Population (million), 2008-2015 167
Figure 44: Demographics, Thailand, Population (million), 2016-2020 168
Figure 45: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2008-2015 169
Figure 46: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2016-2020 170
Figure 47: Demographics, Thailand, Population Distribution (%), 2008-2015 171
Figure 48: Demographics, Thailand, Population Distribution (%), 2016-2020 172
Figure 49: Demographics, Thailand, Births (per 1,000 population), 2008-2015 173
Figure 50: Demographics, Thailand, Mortality (per 1,000 population), 2008-2015 174
Figure 51: Demographics, Major Causes of Mortality, Thailand, Share of Total Mortality (%), 2014 175
Figure 52: Demographics, Thailand, Children Under Five Years of Age, Infant Mortality (per 1,000 live births), 2008-2015 177
Figure 53: Demographics, Thailand, Immunization Rate (%), 2008-2015 178
Figure 54: Demographics, Thailand, Major Causes of Male Mortality (Share %), 2010 179
Figure 55: Demographics, Thailand, Major Causes of Female Mortality (Share %), 2010 180
Figure 56: Demographics, Thailand, Gender Ratio (M/F), 2008-2015 181
Figure 57: Demographics, Thailand, Life Expectancy at Birth (years), 2008-2015 182
Figure 58: Demographics, Thailand, Life Expectancy at Birth (Years), 2016-2020 183
Figure 59: Demographics, Thailand, Gross Enrolment Ratio (%), 2008-2015 184
Figure 60: Demographics, Thailand, Unemployment Rate (%), 2008-2015 186
Figure 61: Demographics, Thailand, Major Diseases, DALYs, 2012 187
Figure 62: Healthcare Infrastructure, Thailand, Hospitals, 2008-2015 189
Figure 63: Healthcare Infrastructure, Thailand, Public and Private Hospitals, 2008-2015 190
Figure 64: Healthcare Infrastructure, Thailand, Hospitals by Standard of Care, Share (%), 2010 191
Figure 65: Healthcare Infrastructure, Thailand, Hospital Beds by Authority and Region, Share (%), 2010 193
Figure 66: Healthcare Infrastructure, Thailand, Hospital Beds (per 1,000 population), 2008-2015 194
Figure 67: Healthcare Infrastructure, Thailand, Doctors (per 1,000 population), 2008-2015 195
Figure 68: Healthcare Infrastructure, Thailand, PM2.5 emissions (µgm/m³), 2008-2015 196
Figure 69: Healthcare Infrastructure, Thailand, CO2 Emissions (Metric Tons Per Capita), 2008-2015 198
Figure 70: Healthcare Infrastructure, Thailand, Dentists (per 100,000 population), 2008-2015 199
Figure 71: Healthcare Infrastructure, Thailand, Nurses (per 100,000 population), 2008-2015 200
Figure 72: Healthcare Infrastructure, Thailand, Pharmacists (per 100,000 population), 2008-2015 201
Figure 73: Healthcare Expenditure (% of GDP), Thailand, 2008-2015 202
Figure 74: Healthcare Expenditure, Thailand, Major Components of Healthcare Expenditure (%), 2012 203
Figure 75: Healthcare Expenditure, Thailand, Public and Private Shares of GDP (%), 2008-2015 204
Figure 76: Healthcare Expenditure, Thailand, R&D Expenditure (% of GDP), 2008-2015 205
Figure 77: Healthcare Market, Thailand, Opportunities and Challenges, 2016 209

  • Pharmaceutical Mergers and Acquisitions Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Apr-2019        Price: US 3000 Onwards        Pages: 138
    Pharmaceutical Mergers and Acquisitions Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharmaceutical Mergers and Acquisitions industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharmaceutical Mergers and Acquisitions manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provide......
  • Pharmerging Contract Manufacturings Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 17-Feb-2019        Price: US 3000 Onwards        Pages: 135
    Pharmerging Contract Manufacturings Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharmerging Contract Manufacturings industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharmerging Contract Manufacturings manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-dept......
  • Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2018
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 344
    The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the ......
  • Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 348
    The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies. The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered i......
  • Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 350
    The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies. The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the royalty financing agreem......
  • Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 457
    The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies. The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered ......
  • Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 2000
    The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the collaborative R&D deals an......
  • Global Academic and Non-Profit Partnering Terms and Agreements 2012-2018: Deal trends, players and financials
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 1000
    Global Academic and Non-Profit Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals Global Academic and Non-Profit Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to c......
  • Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018
    Published: 01-Sep-2018        Price: US 2995 Onwards        Pages: 1000
    "Delivery of this report will take 1-3 days after purchase." The Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides details of the latest merger and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, the report provides details of M&A agreements from 2012 to 2018. The report provides a detailed understan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs